| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_07b71571160c289fbf5fc680dfea513f |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-47 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47 |
| filingDate |
1999-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2001-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b30691ee3e26454c94f0b0a295ae9e4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5301cd671685e303b59391e133118f8d |
| publicationDate |
2001-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-6331550-B1 |
| titleOfInvention |
Methods of use of quinolone compounds against anaerobic pathogenic bacteria |
| abstract |
This invention relates, in part, to newly identified methods of using quinolone antibiotics, particularly a gemifloxacin compound against pathogenic bacteria, especially anaerobic pathogens. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005288300-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004023983-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0238156-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005032813-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0238156-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004180903-A1 |
| priorityDate |
1999-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |